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胸主动脉，组织贴块法培养 VSMCs，Ang Ⅱ刺激 VSMCs 建立细胞增殖模型，
不同浓度 OEA（5,10,20 μmol/ L）和非诺贝特（100 μmol/ L）作用后，用溴脱氧
核苷尿嘧啶（BrdU）掺入的方法检测细胞增殖活性；流式细胞术检测细胞周期
变化；蛋白免疫印迹法（Western blotting）检测对 PPAR-α、p-p38 和 p38 蛋白
表达的影响。为了研究 OEA 的抑制增殖作用机理，给与 p38MAPK 选择性阻断
剂 SB202190 后，观察 OEA 抗增殖和对 p38MAPK 通路影响作用。结果：与 Ang 
Ⅱ组比较，随着 OEA 浓度升高，VSMCs 的增殖受到抑制、G0 /G1 期比例显著升
高，G2 /M 期比例显著降低，且 p-p38 蛋白的表达量降低并呈浓度依赖关系（P < 
0.05，P < 0. 01）。且 OEA 在上调 PPAR-α表达的同时能够抑制 p38 MAPK 的磷
酸化表达。加入 p38MAPK 选择性阻断剂，Ang Ⅱ 诱导的 VSMCs 增殖和 p-p38
表达下降，给与 OEA 后抑制作用更加显著。结论：OEA 对 VSMCs 的增殖有抑













































































Background: Atherosclerosis (AS) is a feature of immune activities chronic 
inflammatory disease. It’s easy to occur plaque ruptured and thrombosis. It can cause 
a series of cardiovascular events and be serious harm to human health. Variety of cells 
in the blood vessels such as vascular endothelial cells, macrophages, monocytes and 
smooth muscle cells are all involved in the development process of atherosclerosis 
happened. Vascular smooth muscle cells (VSMCs) proliferation and migration is a 
vascular restenosis and atherosclerosis formed an important part in the development 
process. 
PPAR alpha and atherosclerosis development and occurrence of closely linked, 
not only because it with lipid metabolism, carbohydrate metabolism closely related, 
but also because of its anti-inflammatory and antiproliferative role. 
Oleoylethanolamide (OEA), a naturally occurring lipid that binds with high affinity to 
the PPAR-α, severs as an endogenous agonist of PPAR-α. Experiments have found 
that OEA by activating PPAR alpha receptors to play the vascular endothelial 
protection, the protection of cerebral ischemia , anti-inflammatory function and so 
on.But the cell proliferation effects have not yet been reported. 
Objective: To investigate the inhibitory effects of oleoylethanolamide on the 
proliferation of cultured rat vascular smooth muscle cells（VSMCs）induced by 
angiotensinⅡ(AngⅡ)and the effects on p38 mitogen-activated protein 
kinase(MAPK)signaling pathway. Methods: VSMCs were primary cultured by tissue 
sticking method. Cell proliferation model was established by stimulation with 
AngⅡ.After incubation with various concentrations of OEA（5、10、20 μmol/ L）for 
24 h,the proliferation effects were measured by using the BrdU cell proliferation assay 
kit.Cell cycle distribution was determined by flow cytometry analysis and the protein 
expression of PPAR-α、p-p38 and p38 were assessed using Western blotting. To 
investigate the mechanism of the anti-proliferation of OEA, a specific inhibitor of 

















VSMCs. Results: Compared with the AngⅡ group，along with the increased 
concentration of OEA，the proliferation of VSMCs was obviously inhibited，the cell 
ratio of G0 /G1 phase obviously increased，and the cell ratio of G2 /M phase 
significantly decreased. Besides，the expression of p-p38 protein decreased in a 
dose-dependent manner（P < 0. 05，P < 0. 01）. OEA markedly up-regulated PPAR-
α, and inhibited the expre ssion of p-p38. SB202190 could attenuate the expression 
of Ang  stimulate proliferation and the phosphorylation of p38MAPK, at the same Ⅱ
time, OEA exert a synergistic effect. Conclusion: OEA had a inhibition on the 
proliferation Of VSMCs,and may act by down-regulating p38MAPK pathway. It 
suggested that PPAR-αligands exert potential anti-proliferative effects in modulation 
various inflammatory processes such as atherogenesis. 












































第一章 前 言 .............................................1 
1.1 动脉粥样硬化的发病机制 ……………………………………………………1 
1.2 平滑肌细胞与动脉粥样硬化 …………………………………………………3 
1.3 炎症相关信号通路与动脉粥样硬化 …………………………………………5 
1.3.1 NF-κB 信号通路与动脉粥样硬化..............................5 
1.3.2 JAK－STAT 信号通路与动脉粥样硬化 ...........................5 
1.3.3 MAPK 信号通路与动脉粥样硬化 . ..............................6 
1.4 血管紧张素Ⅱ与炎性信号转导机制 ……………………………………….8 
1.4.1 Ang Ⅱ的生物学特点 ........................................9 
1.4.2 Ang Ⅱ- AT1R 与信号转导通路的关系 ......................10 
1.5 PPAR-alpha 与动脉粥样……………………………………………………11 
1.5.1 过氧化物酶体增殖物激活受体-α简介 .. ....................12 
1.5.2 PPAR-α与 AS 早期发生发展之间的关系 . ...................14 
1.5.3 PPAR-α与 AS 后期发生发展之间的关系 . ...................14 
1.6 油酰乙醇胺(OEA)的简介 .…………………………………………………15 
1.6.1 OEA 的生物合成和降解 ....................................15 
1.6.2 OEA 的生理活性 . ..........................................16 
1.7 本论文的主要内容和研究意义. .…………………………………………19 
第二章 油酰乙醇胺对 Ang Ⅱ诱导的血管平滑肌细胞增殖的影响
 ........................................................20 
2.1 大鼠胸主动脉血管平滑肌细胞的培养与鉴定 .……………………………20 
2.1.1 实验仪器和试剂 ..........................................20 
2.1.2 实验动物 .................................................21 

















2.1.4 实验结果与讨论 ..........................................22 
2.2 油酰乙醇胺对 Ang Ⅱ诱导的血管平滑肌细胞增殖的影响 . …………….23 
2.2.1 实验仪器和试剂 ..........................................24 
2.2.2 实验方法 ................................................24 
2.2.3 实验结果与讨论 ..........................................25 
2.3 油酰乙醇胺对 Ang Ⅱ诱导的血管平滑肌细胞周期的影响 . …………….27 
2.3.1 实验仪器和试剂 ..........................................28 
2.3.2 实验方法. ................................................28 
2.3.3 实验结果与讨论 ..........................................29 
2.4 本章小结 ………………………………………………………….…………30 
第三章 油酰乙醇胺对 Ang Ⅱ诱导的血管平滑肌细胞增殖的
机制研究 ...............................................32 
3.1 油酰乙醇胺对 VSMCs 内 PPAR-α、p-p38 和 p38 蛋白表达的影响 ………32 
3.1.1 实验仪器和试剂 ....................................... ...32 
3.1.2 实验方法 ................................................ 34 
3.1.3 实验结果与讨论 .......................................... 37 
3.2 油酰乙醇胺对 Ang Ⅱ诱导的 VSMCs 增殖的影响与 p38MAPK 的关系 ……42 
3.2.1 实验仪器和试剂 ....................................... ...43 
3.2.2 实验方法 ................................................ 43 
3.2.3 实验结果与讨论 .......................................... 44 
3.3 本章小结 .................................................... 48 





















Table of Contents 
Abstract in Chinese………………………………….…………………………Ⅰ 
Abstract in English………………………………….…………………………Ⅲ 
Chapter 1 Introduction………………………………………………………...….…1 
1.1 Pathogenesis of atherosclerosis……………………………………..…….….1 
1.2 Vascular smooth muscle cells of atherosclerosis……………………………3 
1.3 Signal transduction of inflammation and atherosclerosis………..………..5 
1.3.1 NF-κB signal pathways and atherosclerosis……………….……...…5 
1.3.2 JAK-STAT signal pathways and atherosclerosis………..………...……5 
1.3.3 MAPK signal pathways and atherosclerosis…………..……………….6 
1.4 Angiotensin Ⅱ and Signal transduction of inflammation….……….……..8 
1.4.1 Ang Ⅱ biological characteristics ……….……….……………………9 
1.4.2 Ang Ⅱ-AT1R and signal transduction pathways………………………10 
1.5 PPAR-alpha and Atherosclerosis ...................................................................11 
1.5.1 Overview of PPAR-α................................................................................12 
1.5.2 PPAR-αin the early Atherosclerosis........................................................14 
1.5.3 PPAR-αin the advanced Atherosclerosis................................................14 
1.6 Overview of oleoyethanolamide (OEA) .........................................................15 
1.6.1 Biosynthesis and Hydrolysis of OEA .....................................................15 
1.6.2 Bioactivities of OEA...................................................................................16 
1.7 The main subject of research content.............................................................19 
Chapter 2 Effects of oleoylethanolamide on proliferation of VSMCs 
induced by angiotensin Ⅱ……………………………………………..20 
2.1 rVSMCs culture and identification.................................................................20 
2.1.1 Experimental apparatus and reagents..........................................................20 
2.1.2 Experimental animals…………………………..........................................21 

















2.1.4 Experimental results and discussion ..........................................................22 
2.2 The influence of OEA on proliferation of vascular smooth muscle  
cells induced by angiotensin Ⅱ……………………………………………...23 
2.2.1 Experimental apparatus and reagents..........................................................24 
2.2.2 Experimental Methods ...............................................................................24 
2.2.3 Experimental results and discussion ..........................................................25 
2.3 The influence of OEA on VSMCs cell cycle…………………………...27 
2.3.1 Experimental apparatus and reagents..........................................................28 
2.3.2 Experimental Methods ...............................................................................28 
2.3.3 Experimental results and discussion ..........................................................29 
2.4 Chapter Summary……………………………………………………….….30 
Chapter 3 Mechanism of OEA on anti-proliferation effects in  
Ang Ⅱ induced VSMCs…………………………………………..…32 
3.1 Effects of OEA on protein expression of PPAR-α、p-p38 and p38 in 
VSMCs........................................................................................................................ 32 
3.1.1 Experimental apparatus and reagents..........................................................32 
3.1.2 Experimental Methods ...............................................................................34 
3.1.3 Experimental results and discussion………………………………….......37 
3.2 Relationship between effects of OEA on Ang Ⅱ-mediated responses in 
VSMCs and p38MAPK………………………………………………..……………42 
3.2.1 Experimental apparatus and reagents..........................................................43 
3.2.2 Experimental Methods ...............................................................................43 
3.2.3 Experimental results and discussion……………………………………44 
3.3 Chapter Summary……………………………………………………………48 






















































































因子，其中肿瘤坏死因子 α（TNF-α）、白细胞介素 1（IL-1）和白细胞介素 6
（IL-6）等可刺激内皮细胞表达黏附分子，如此循环反复，产生了大量的泡沫细
胞并堆积形成脂纹[9,10] 。 

































图 1.1 动脉粥样硬化发病机制 
Fig.1.1 Atherosclerosis pathogenesis 
１.2 平滑肌细胞与动脉粥样硬化 
经过近些年的研究，人们认识到平滑肌细胞（SMC）增殖、游走进入内膜及






























AS 形成中 SMC 的增殖和表型转化有赖于多种生长因子的作用。血管内皮
生长因子（vascular endothelial growth factor, VEGF），它与正常血管和病理血管
的生成有着紧密联系[13]。AS 状态下，SMC 在诸多因素的作用下，可由收缩型
转化为合成型，分泌 VEGF。VEGF 是通过刺激成纤维细胞生长因子-2（fibroblast 




原纤维、巨噬细胞和造血细胞中表达[15]。激活的 TGF-β1 与 SMC 的迁移和增殖
密切相关，是 AS 形成和发展的促进因子和增强因子[16]。 
SMC 的增殖与细胞因子密切相关。细胞因子是一类调节细胞多种功能的活
性肽类物质。其中白细胞介素（ILs）和肿瘤坏死因子-α（tumor necrosis factor α， 
TNF-α）是重要的促细胞有丝分裂物质。目前所知，IL-1、IL-6 具有促进 SMC 增
殖的作用，IL-4 具有抑制 SMC 增殖的作用，IL-8 可以刺激 SMC 的迁移，而 IL-2 















Degree papers are in the “Xiamen University Electronic Theses and Dissertations Database”. Full
texts are available in the following ways: 
1. If your library is a CALIS member libraries, please log on http://etd.calis.edu.cn/ and submit
requests online, or consult the interlibrary loan department in your library. 
2. For users of non-CALIS member libraries, please mail to etd@xmu.edu.cn for delivery details.
厦
门
大
学
博
硕
士
论
文
摘
要
库
